International Conference on

Molecular Cancer and Cancer Cell Biology (ICMCCCB-27)

Conference Date

6th Apr - 7th Apr 2027

Conference Venue

Seeb, Oman

Conference Mode

Hybrid Conference
Proudly organized by:- Science Leagues

"Join global experts in Molecular Cancer and Cancer Cell Biology"

Registration Options →

View all registration categories and choose the best fit.

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 6–7 April 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 3 SDGs SDGs 3, 4 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

6 APR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Protein Kinases in Cancer Signaling
    34
    Track Overview

    This track will explore the role of protein kinases in the regulation of signal transduction pathways involved in cancer. Discussions will focus on their potential as therapeutic targets and the implications for cancer treatment.

    Track 02
    Steroid Hormones and Cancer Receptors
    34
    Track Overview

    This session will examine the interactions between steroid hormones and their receptors in the context of cancer biology. Emphasis will be placed on understanding their roles in tumor progression and therapeutic strategies.

    Track 03
    Transgenic Models in Cancer Research
    9
    Track Overview

    This track will highlight the use of transgenic mice as models for studying cancer development and progression. Participants will discuss advancements in genetic engineering techniques and their applications in cancer research.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Mechanisms of Apoptosis in Cancer
    34
    Track Overview

    This session will delve into the mechanisms of apoptosis and their dysregulation in cancer cells. The focus will be on therapeutic approaches that aim to restore apoptotic pathways in tumors.

    Track 05
    RNA Interference in Cancer Therapy
    39
    Track Overview

    This track will cover the applications of RNA interference technology in cancer biology and treatment. Researchers will present innovative strategies for utilizing RNAi to target oncogenes and enhance therapeutic efficacy.

    Track 06
    Tumor Virology and Cancer Pathogenesis
    34
    Track Overview

    This session will explore the role of viral infections in the initiation and progression of cancer. Discussions will include the mechanisms by which viruses contribute to carcinogenesis and potential therapeutic interventions.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

7 APR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Carcinogenesis and Mutagenesis Mechanisms
    34
    Track Overview

    This track will focus on the molecular mechanisms underlying carcinogenesis and mutagenesis. Participants will share insights into genetic and environmental factors that contribute to cancer development.

    Track 08
    Advances in Cancer Science and Therapy
    39
    Track Overview

    This session will highlight recent advancements in cancer science, including novel therapeutic approaches and technologies. The goal is to foster discussions on integrating these advancements into clinical practice.

    Track 09
    Integrative Approaches in Cancer Research
    34
    Track Overview

    This track will emphasize the importance of integrative methodologies in cancer research, combining various disciplines to enhance understanding and treatment of cancer. Participants will discuss case studies and collaborative efforts.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Metabolomics in Cancer Biology
    39
    Track Overview

    This session will explore the role of metabolomics in understanding cancer biology and its potential for identifying biomarkers. Researchers will present findings on metabolic alterations in cancer cells and their implications for therapy.

    Track 11
    Innovations in Anti-Cancer Drug Discovery
    39
    Track Overview

    This track will focus on novel approaches to anti-cancer drug discovery and development. Participants will discuss cutting-edge research, including high-throughput screening and targeted therapies.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure

Be Part of ICMCCCB-27

Submit your research or complete your conference registration.